Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction.

about

A Needleless Liquid Jet Injection Delivery Approach for Cardiac Gene Therapy.

P2860

Q45862442-CD371121-4586-4C0B-891C-7FB9E918E869

P2860

Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction.

Item

http://www.wikidata.org/entity/Q36547398

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Liquid jet delivery method fea ...... g acute myocardial infarction.

@ast

Liquid jet delivery method fea ...... g acute myocardial infarction.

@en

type

Item

label

Liquid jet delivery method fea ...... g acute myocardial infarction.

@ast

Liquid jet delivery method fea ...... g acute myocardial infarction.

@en

prefLabel

Liquid jet delivery method fea ...... g acute myocardial infarction.

@ast

Liquid jet delivery method fea ...... g acute myocardial infarction.

@en

P1476

Liquid jet delivery method fea ...... g acute myocardial infarction.

@en

P2093

A P Kendle

http://www.w3.org/2001/XMLSchema#string

A S Fargnoli

http://www.w3.org/2001/XMLSchema#string

C R Bridges

http://www.w3.org/2001/XMLSchema#string

M G Katz

http://www.w3.org/2001/XMLSchema#string

N Steuerwald

http://www.w3.org/2001/XMLSchema#string

R D Williams

http://www.w3.org/2001/XMLSchema#string

P2860

S100A1: a regulator of myocardial contractility

Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1

Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance

Ultrastructural distribution of the S100A1 Ca2+-binding protein in the human heart

Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model

Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction

CD38: an ecto-enzyme at the crossroads of innate and adaptive immune responses

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

P2888

gt.2015.100

P304

151-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2015.100

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26461176

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

4742412

http://www.w3.org/2001/XMLSchema#string

Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction.

about

P2860

P2860

Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932